Skip to content
Search

Latest Stories

UK's hospital waiting times among worst in high-income countries, survey finds

UK's hospital waiting times among worst in high-income countries, survey finds

In 2023, 61% of people in the UK reported waiting more than 4 weeks for a specialist appointment, a significant rise from just 14% in 2013 

The UK's performance in hospital-based care is falling behind other high-income countries, according to a new report published by the Health Foundation.

For hospital care waiting times, the UK ranked among the worst in a public survey of 10 nations, with 11 per cent of people waiting a year or more for a specialist appointment and 19 per cent facing the same delay for non-emergency surgery. Only Canada had comparable figures.


The report published on Thursday (22 August) also pointed out that waiting times for specialist appointments have increased more rapidly in the UK than in other countries. In 2023, 61 per cent of people in the UK reported waiting more than four weeks for a specialist appointment, a significant rise from just 14 per cent in 2013.

Over 21,000 people from across 10 developed countries, including over 3,000 from the UK, participated in the 2023 Commonwealth Fund survey.

The survey analysis highlighted key areas where the UK performs poorly on hospital-based care, including long waits for specialist care, lack of access to out-of-hours care, and high cost of treatments like dental care.

In terms of general practice, the UK ranked among the better-performing countries, with 42 per cent of people reporting same or next-day appointments.

However, the report highlights several areas where the nation falls short.

  • Only 16 per cent of UK respondents reported it was ‘very’ or ‘somewhat easy’ to get medical care in the evenings and weekends without going to A&E.
  • The UK ranks near the bottom on people’s experiences with GPs, particularly in having things clearly explained and spending enough time with their doctor.
  • Additionally, the UK performed poorly on care coordination between healthcare professionals such as GPs and specialists.

As per the report, there has been a significant increase in healthcare affordability issues in the UK since 2013.

In the 2023 survey, 26 per cent of UK respondents reported skipping dental care or checkups due to cost, a sharp rise from just six per cent of people surveyed in 2013.

The report noted that while the NHS remains largely free at the point of use, the percentage of people who avoided visiting or consulting with a doctor due to financial concerns has tripled over the past decade, from two per cent in 2013 to seven per cent in 2023, likely driven by recent increases in living costs.

Ruth Thorlby, Assistant Director of Policy at the Health Foundation, said: "These findings show the UK consistently coming near the bottom of the pack on people’s experience of healthcare compared to other high-income countries.”

“It sheds yet more light on just how much work the government has to do to get the NHS back on its feet.”

Thorlby noted that while the UK is not alone in facing healthcare challenges, the pandemic's impact, combined with below-average spending growth, has left the NHS in a “fragile state.”

She appreciated the government's focus on reducing waiting lists, but noted that it can “only be done with a concerted effort to improve primary care and ensuring good coordination between hospitals and GPs.”

Thorlby stressed that national and local health leaders must be vigilant against “creeping costs” that could deny people access to healthcare.

She pointed out that this issue is especially evident in dental care, where increasing numbers of people are avoiding treatment due to costs.

“If these trends continue, the risk is that more and more people, particularly from deprived communities, will delay seeking care, which could store up more health problems in the future,” she said.

Thorlby concluded that while there are no quick fixes, the NHS can recover with the right mix of “policy change, innovation and investment.”

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less